title: 186Rhenium-labeled anti-CD20 antibody radioimmunotherapy followed by autologous peripheral blood stem cell transplantation in patients with relapsed or refractory non-Hodgkin lymphoma.
authors.forename: Stefan
authors.initials: S
authors.lastname: Knop
authors.forename: Andreas
authors.initials: A
authors.lastname: Jakob
authors.forename: Lothar
authors.initials: L
authors.lastname: Kanz
authors.forename: Holger
authors.initials: H
authors.lastname: Hebart
authors.forename: Roland
authors.initials: R
authors.lastname: Bares
authors.forename: Bernhard
authors.initials: B
authors.lastname: Dohmen
mesh_terms: D000328:Adult; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D058846:Antibodies, Monoclonal, Murine-Derived; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D008228:Lymphoma, Non-Hodgkin / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D036102:Peripheral Blood Stem Cell Transplantation; D016499:Radioimmunotherapy; D011868:Radioisotopes / Q000627:therapeutic use; D012211:Rhenium / Q000627:therapeutic use; D000069283:Rituximab; D014182:Transplantation, Autologous
chemical_list: D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D011868:Radioisotopes; D000069283:Rituximab; D012211:Rhenium